<DOC>
	<DOCNO>NCT00021424</DOCNO>
	<brief_summary>RATIONALE : Vaccines may make body build immune response kill tumor cell . PURPOSE : Phase I trial study effectiveness vaccine therapy treat patient stage IV head neck cancer .</brief_summary>
	<brief_title>Vaccine Therapy Treating Patients With Stage IV Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerate dose dose-limiting toxic effect recombinant fowlpox-TRICOM vaccine patient advance squamous cell carcinoma oral cavity oropharynx nodal dermal metastasis . - Determine safety profile regimen patient . - Determine clinical activity regimen , term inflammation injection site ( ) disease regression stabilization , patient . OUTLINE : This dose-escalation study . Patients receive recombinant fowlpox-TRICOM vaccine ( rF-TRI ) intralesionally week 0 , 3 , 8 . Beginning week 16 , patient may receive additional rF-TRI every 8 week absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos rF-TRI maximum tolerate dose ( MTD ) determine . The MTD define dose precede least 2 3 2 6 patient experience dose-limiting toxicity . Patients follow 1 year . PROJECTED ACCRUAL : A total 20 patient accrue study .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage IV squamous cell carcinoma oral cavity oropharynx nodal dermal metastasis current available treatment likely offer survival advantage result significant palliation Unresectable locoregional recurrence maximum radiotherapy OR Local disease unresectable distant metastasis involve : Base skull Prevertebral fascia Deep neck muscle Carotid artery ( require resection ) Nasopharynx and/or pterygoid muscle Ineligible receive radiotherapy head neck study Primary intraoral lesion must measurable accessible intralesional injection No metastatic brain lesion , cerebral metastasis , leptomeningeal disease PATIENT CHARACTERISTICS : Age : 18 Performance status : Zubrod 02 Life expectancy : At least 2 month Hematopoietic : Absolute neutrophil count great 1,000/mm^3 Platelet count great 100,000/mm^3 Hemoglobin great 8 g/dL Hepatic : Bilirubin le 1.5 mg/dL AST/ALT le 4 time upper limit normal ( ULN ) PT/PTT le 1.5 time ULN Renal : Creatinine le 2.0 mg/dL OR Creatinine clearance great 60 mL/min Cardiovascular : No evidence congestive heart failure No serious cardiac dysrhythmia No evidence recent prior myocardial infarction EKG No clinical coronary artery disease Neurologic : No history seizures concurrent seizure disorder No evidence encephalitis , multiple sclerosis , structural brain lesion ( ) clinical radiological evaluation Immunologic : No risk immune system compromise HIV negative No hypersensitivity egg No significant history allergy ( e.g. , anaphylaxis angioedema ) Other : No active chronic infection No serious concurrent medical illness No malignancy unless previously treat curative intent evidence persistent recurrent disease Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior immunotherapy recover Chemotherapy : No 2 prior chemotherapy regimen At least 4 week since prior chemotherapy recover Endocrine therapy : At least 4 week since prior systemic corticosteroid No concurrent systemic corticosteroid Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy recover No prior radiotherapy 50 % nodal group Surgery : More 4 week since prior surgery primary metastatic lesion recover No prior splenectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2002</verification_date>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>skin metastasis</keyword>
</DOC>